Abstract
DNA·RNA hybrids are non-canonical nucleic acid structures of fundamental importance for gene regulation and disease. In this issue of Chem, Terrazas et al. investigate the origins and biological consequences of the DNA·RNA asymmetry and deliver novel insights for improving applications of key enzymes, such as RNase H and CRISPR-Cas9.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
